{"id":"https://openalex.org/W2170352583","doi":"https://doi.org/10.1161/01.atv.0000187465.55507.85","title":"Inhibition of the Renin-Angiotensin System Prevents Free Fatty Acid\u2013Induced Acute Endothelial Dysfunction in Humans","display_name":"Inhibition of the Renin-Angiotensin System Prevents Free Fatty Acid\u2013Induced Acute Endothelial Dysfunction in Humans","alternate_titles":[],"publication_year":2005,"publication_date":"2005-09-23","ids":{"openalex":"https://openalex.org/W2170352583","doi":"https://doi.org/10.1161/01.atv.0000187465.55507.85","mag":"2170352583","pmid":"https://pubmed.ncbi.nlm.nih.gov/16179595"},"language":"en","primary_location":{"id":"doi:10.1161/01.atv.0000187465.55507.85","doi":"https://doi.org/10.1161/01.atv.0000187465.55507.85","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.atv.0000187465.55507.85","pdf_url":null,"source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2170352583"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087471546","display_name":"Saiko Watanabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32915989","display_name":"University of the Ryukyus","ror":"https://ror.org/02z1n9q24","country_code":"JP","type":"education","lineage":["https://openalex.org/I32915989"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Saiko Watanabe","raw_affiliation_strings":["From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","Saiko Watanabe From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]},{"raw_affiliation_string":"Saiko Watanabe From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091038937","display_name":"Tatsuya Tagawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32915989","display_name":"University of the Ryukyus","ror":"https://ror.org/02z1n9q24","country_code":"JP","type":"education","lineage":["https://openalex.org/I32915989"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tatsuya Tagawa","raw_affiliation_strings":["From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","Tatsuya Tagawa From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]},{"raw_affiliation_string":"Tatsuya Tagawa From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053781383","display_name":"Ken Yamakawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32915989","display_name":"University of the Ryukyus","ror":"https://ror.org/02z1n9q24","country_code":"JP","type":"education","lineage":["https://openalex.org/I32915989"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ken Yamakawa","raw_affiliation_strings":["From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","Ken Yamakawa From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]},{"raw_affiliation_string":"Ken Yamakawa From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091249720","display_name":"Michio Shimabukuro","orcid":"https://orcid.org/0000-0001-7835-7665","observed_orcids":["https://orcid.org/0000-0001-7835-7665"]},"institutions":[{"id":"https://openalex.org/I32915989","display_name":"University of the Ryukyus","ror":"https://ror.org/02z1n9q24","country_code":"JP","type":"education","lineage":["https://openalex.org/I32915989"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michio Shimabukuro","raw_affiliation_strings":["From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","Michio Shimabukuro From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]},{"raw_affiliation_string":"Michio Shimabukuro From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075058891","display_name":"Shinichiro Ueda","orcid":"https://orcid.org/0000-0003-0456-0841","observed_orcids":["https://orcid.org/0000-0003-0456-0841"]},"institutions":[{"id":"https://openalex.org/I32915989","display_name":"University of the Ryukyus","ror":"https://ror.org/02z1n9q24","country_code":"JP","type":"education","lineage":["https://openalex.org/I32915989"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shinichiro Ueda","raw_affiliation_strings":["From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","Shinichiro Ueda From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]},{"raw_affiliation_string":"Shinichiro Ueda From the Department of Clinical Pharmacology and Therapeutics (S.W., T.T., K.Y., S.U.) and the Second Department of Internal Medicine (M.S.), University of the Ryukyus School of Medicine, Okinawa, Japan","institution_ids":["https://openalex.org/I32915989"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075058891"],"corresponding_institution_ids":["https://openalex.org/I32915989"],"apc_list":null,"apc_paid":null,"fwci":3.4318,"has_fulltext":false,"cited_by_count":83,"citation_normalized_percentile":{"value":0.91812022,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"25","issue":"11","first_page":"2376","last_page":"2380"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.8237000107765198,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.8237000107765198,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.16040000319480896,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-angiotensin-system-blockade","display_name":"renin-angiotensin system blockade","score":0.9110000133514404},{"id":"https://openalex.org/keywords/free-fatty-acids","display_name":"free fatty acids","score":0.9829999804496765},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9940000176429749},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.796999990940094},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.8939999938011169},{"id":"https://openalex.org/keywords/perindopril","display_name":"perindopril","score":1.0},{"id":"https://openalex.org/keywords/acetylcholine-induced-vasodilation","display_name":"acetylcholine-induced vasodilation","score":0.8999999761581421},{"id":"https://openalex.org/keywords/forearm-blood-flow","display_name":"forearm blood flow","score":0.8149999976158142},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.7390000224113464},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.6959999799728394},{"id":"https://openalex.org/keywords/vitamin-c","display_name":"vitamin C","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.8736840486526489},{"id":"https://openalex.org/C2779200603","wikidata":"https://www.wikidata.org/wiki/Q277785","display_name":"Perindopril","level":3,"score":0.7963392734527588},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7504255771636963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7307608723640442},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.6010777950286865},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.58122718334198},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.5686584115028381},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5359606742858887},{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.4759637713432312},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.46857738494873047},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.42640578746795654},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.396350622177124},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.20020025968551636}],"mesh":[{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005230","descriptor_name":"Fatty Acids, Nonesterified","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010991","descriptor_name":"Plethysmography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012039","descriptor_name":"Regional Blood Flow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012039","descriptor_name":"Regional Blood Flow","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D014664","descriptor_name":"Vasodilation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014664","descriptor_name":"Vasodilation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019323","descriptor_name":"omega-N-Methylarginine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020913","descriptor_name":"Perindopril","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1161/01.atv.0000187465.55507.85","doi":"https://doi.org/10.1161/01.atv.0000187465.55507.85","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.atv.0000187465.55507.85","pdf_url":null,"source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},{"id":"pmid:16179595","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16179595","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, thrombosis, and vascular biology","raw_type":"Journal Article"},{"id":"mag:2886851948","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/full/10.1161/01.atv.0000187465.55507.85?related-urls=yesl25%2F11%2F2376","pdf_url":null,"source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Arteriosclerosis Thrombosis and Vascular Biology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W269784407","https://openalex.org/W1966509583","https://openalex.org/W1982811953","https://openalex.org/W1982920623","https://openalex.org/W1988393630","https://openalex.org/W1995407151","https://openalex.org/W2004648485","https://openalex.org/W2009639847","https://openalex.org/W2012214559","https://openalex.org/W2026021043","https://openalex.org/W2030652589","https://openalex.org/W2035280687","https://openalex.org/W2046591933","https://openalex.org/W2050957687","https://openalex.org/W2076724721","https://openalex.org/W2077688067","https://openalex.org/W2086785365","https://openalex.org/W2103745497","https://openalex.org/W2109168147","https://openalex.org/W2112122483","https://openalex.org/W2133217116","https://openalex.org/W2135961756","https://openalex.org/W2141018820","https://openalex.org/W2156141764","https://openalex.org/W2163978606","https://openalex.org/W2208872067","https://openalex.org/W2405166251","https://openalex.org/W3150464829"],"related_works":["https://openalex.org/W2118231738","https://openalex.org/W2362812864","https://openalex.org/W2757897401","https://openalex.org/W2086785365","https://openalex.org/W2057986873","https://openalex.org/W2171457468","https://openalex.org/W2004648485","https://openalex.org/W2171761939","https://openalex.org/W2039237702"],"abstract_inverted_index":{"OBJECTIVE:":[0],"An":[1],"elevated":[2],"free":[3],"fatty":[4],"acid":[5],"(FFA)":[6],"level":[7],"impairs":[8],"endothelium-dependent":[9],"vasodilation":[10],"in":[11,24,48,68,165,182,193],"humans,":[12],"which":[13,157],"may":[14,158],"be":[15],"pathophysiologically":[16],"relevant":[17],"to":[18,108,128],"the":[19,31,36,94,106,117,126,161,177,187],"development":[20],"of":[21,33,35,55,66,76,96,133],"endothelial":[22,42,141,148,171],"dysfunction":[23,172],"patients":[25,166,194],"with":[26,93,119,167,195],"insulin":[27,168],"resistance.":[28],"We":[29],"investigated":[30,92],"effect":[32],"inhibition":[34,192],"renin-angiotensin":[37],"system":[38],"(RAS)":[39],"on":[40],"FFA-induced":[41,140,147],"dysfunction.":[43,142,149],"METHODS":[44],"AND":[45],"RESULTS:":[46],"Changes":[47],"forearm":[49],"blood":[50],"flow":[51],"during":[52],"intra-arterial":[53],"infusion":[54,65,89],"acetylcholine":[56,109],"were":[57],"measured":[58],"by":[59,110,154],"plethysmography":[60],"before":[61],"and":[62,176],"after":[63,87],"systemic":[64],"lipid/heparin":[67,88,155],"10":[69],"healthy":[70],"subjects":[71],"given":[72],"a":[73],"single":[74,131],"dose":[75,132],"placebo,":[77],"losartan":[78,135],"(50":[79],"mg),":[80],"or":[81,99,136],"perindopril":[82,137],"(8":[83],"mg).":[84],"Endothelial":[85],"function":[86],"was":[90],"also":[91,145],"coinfusion":[95],"vitamin":[97],"C":[98,144],"NG-monomethyl-L-arginine":[100],"(L-NMMA).":[101],"Elevated":[102,151],"FFA":[103,122,152,197],"significantly":[104],"reduced":[105],"response":[107,118,127],"37.7%":[111],"(P=0.0096)":[112],"without":[113],"L-NMMA,":[114,120],"but":[115],"not":[116,124],"whereas":[121],"did":[123],"affect":[125],"nitroprusside.":[129],"The":[130],"either":[134],"completely":[138],"prevented":[139,146],"Vitamin":[143],"CONCLUSIONS:":[150],"levels":[153],"infusion,":[156],"partly":[159],"mimic":[160],"abnormal":[162],"lipid":[163],"profile":[164],"resistance,":[169],"caused":[170],"via":[173],"RAS":[174,191],"activation":[175],"presumably":[178],"resultant":[179],"oxidative":[180],"stress":[181],"humans.":[183],"Our":[184],"results":[185],"suggest":[186],"therapeutic":[188],"rationale":[189],"for":[190],"high":[196],"levels.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2170352583","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
